US Broker Ratings

Protagonist Therapeutics (PTGX) Stock Analysis: Exploring Growth Potential with Promising Pipeline

Protagonist Therapeutics, Inc. (NASDAQ: PTGX), a biopharmaceutical company specializing in peptide therapeutics, has been capturing investor interest with its robust pipeline and notable market presence. Operating within the healthcare sector..

Privia Health Group, Inc. (PRVA): Investor Outlook with a Promising 17.89% Upside

Privia Health Group, Inc. (NASDAQ: PRVA) is making waves in the healthcare sector as a prominent player in the health information services industry. With a market capitalization of $3.16 billion,..

NewAmsterdam Pharma (NAMS) Investor Outlook: Strong Buy Ratings and Promising Growth Potential

NewAmsterdam Pharma Company N.V. (NASDAQ: NAMS), a burgeoning force in the biotechnology sector, has been capturing investor interest with its innovative approach to tackling metabolic diseases. Based in Naarden, Netherlands,..

Amicus Therapeutics, Inc. (FOLD) Stock Analysis: 75% Potential Upside Awaits Investors

Amicus Therapeutics, Inc. (NASDAQ: FOLD) is making waves in the biotechnology sector with its innovative approach to treating rare diseases. Headquartered in Princeton, New Jersey, this healthcare-focused company holds a..

Centessa Pharmaceuticals (CNTA) Stock Analysis: A Promising 35% Upside as Analysts Rally Behind This Biotech

Centessa Pharmaceuticals plc (NASDAQ: CNTA), a clinical-stage biotechnology company headquartered in Altrincham, UK, is capturing the attention of investors with its robust pipeline targeting unmet medical needs. With a market..

Twist Bioscience Corporation (TWST) Stock Analysis: A 15% Upside in Synthetic DNA Innovation

Twist Bioscience Corporation (NASDAQ: TWST) is garnering attention in the investment community with its significant presence in the healthcare sector, particularly within diagnostics and research. With a market capitalization of..

Progyny, Inc. (PGNY) Stock Analysis: Exploring a 44.65% Potential Upside in the Healthcare Sector

Progyny, Inc. (NASDAQ: PGNY) has captured investor interest with a compelling 44.65% potential upside, according to the latest analyst ratings. As a rising star in the healthcare sector, specifically within..

Apogee Therapeutics, Inc. (APGE) Investor Outlook: Analysts See 67.70% Potential Upside

Apogee Therapeutics, Inc. (APGE), a burgeoning player in the biotechnology sector, has been garnering investor attention with its promising pipeline in the treatment of various inflammatory and immunological diseases. Headquartered..

Galapagos NV (GLPG) Stock Analysis: Navigating the Waters of Biotech with Potential Challenges Ahead

Galapagos NV (GLPG), a prominent player in the biotechnology sector, is navigating a complex landscape as it ventures into oncology and immunology. Headquartered in Mechelen, Belgium, this biotech firm has..

Arrowhead Pharmaceuticals (ARWR) Investor Outlook: Promising Growth with a 20% Upside Potential

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR), a key player in the biotechnology sector focused on developing breakthrough treatments for intractable diseases, is attracting significant attention from individual investors, thanks to its..

Ardent Health, Inc. (ARDT) Stock Analysis: Exploring a 26% Upside Potential

Ardent Health, Inc. (ARDT), a prominent player in the medical care facilities sector, is capturing investor attention with its robust growth trajectory and compelling upside potential. With a market capitalization..

Metsera, Inc. (MTSR) Stock Analysis: Exploring the Growth Potential in Biotechnology with a 6.42% Upside

Metsera, Inc. (NASDAQ: MTSR) is capturing the attention of investors as it navigates the promising, yet challenging, biotechnology sector. As a clinical-stage company focused on developing innovative treatments for obesity..

Addus HomeCare Corporation (ADUS) Stock Analysis: Exploring a 16.84% Potential Upside for Investors

In the dynamic landscape of healthcare services, Addus HomeCare Corporation (NASDAQ: ADUS) stands out with a robust market presence and a notable potential upside of 16.84% according to recent analyst..

QuidelOrtho Corporation (QDEL) Stock Analysis: Navigating the 32.86% Potential Upside Amidst Healthcare Market Challenges

QuidelOrtho Corporation (NASDAQ: QDEL), a prominent player in the healthcare sector, specializes in diagnostic testing solutions that serve an array of medical needs globally. As it navigates the complexities of..

BioCryst Pharmaceuticals, Inc. (BCRX) Investor Outlook: Exploring a Potential 177% Upside in the Biotech Arena

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) has consistently captured investor attention within the healthcare sector, particularly among specialty and generic drug manufacturers. With its headquarters in Durham, North Carolina, BioCryst is..

Viking Therapeutics, Inc. (VKTX) Stock Analysis: Unveiling a 157% Upside Potential in Biotechnology

Viking Therapeutics, Inc. (NASDAQ: VKTX) is capturing investor attention with its robust growth potential in the biotechnology sector. Specializing in developing innovative therapies for metabolic and endocrine disorders, this clinical-stage..

Warby Parker Inc. (WRBY) Stock Analysis: Eyeing a 23.64% Upside Amid Robust Revenue Growth

Warby Parker Inc. (WRBY), a prominent player in the healthcare sector’s medical instruments and supplies industry, is making waves with a market capitalization of $2.62 billion. This New York-headquartered company..

HUTCHMED (China) Limited (HCM) Stock Analysis: A 51.71% Upside Potential and Strategic Partnerships Fuel Investor Interest

HUTCHMED (China) Limited (HCM), a dynamic player in the healthcare sector, stands out with a market cap of $2.6 billion and a compelling growth narrative. Operating from Hong Kong, the..

Crinetics Pharmaceuticals, Inc. (CRNX) Stock Analysis: Exploring an 81% Potential Upside in the Biotech Sector

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX), a prominent player in the biotechnology industry, is currently capturing significant attention from investors, particularly those with an eye for potential growth opportunities in the..

Scholar Rock Holding Corporation (SRRK) Investor Outlook: A 52.61% Upside Opportunity in Biotech

Scholar Rock Holding Corporation (NASDAQ: SRRK) is capturing investor attention with a potential upside of 52.61%, a compelling figure for those interested in the biotechnology sector. As a company at..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds